Drug General Information
Drug ID
D0NJ3V
Former ID
DAP000959
Drug Name
Papaverine
Synonyms
Alapav; Cardiospan; Cardoverina; Ceraspan; Cerebid; Cerespan; Delapav; Dilaves; Dispamil; Drapavel; Durapav; Dynovas; Forpavin; Genabid; Mesotina; Myobid; Pameion; Pamelon; Panergon; Papacon; Papalease; Papanerin; Papanerine; Papaverin; Papaverina; Papaversan; Pavabid; Pavacap; Pavacels; Pavacen; Pavacot; Pavagen; Pavarine; Pavatest; Pavatine; Pavatym; Paverolan; Paveron; Pavnell; Robaxapap; Vasal; Chlorhydrate de papaverine; PAP H; Papavarine chlorhydrate; Papaverina [Italian]; Papaverine Hcl; Papaverine [BAN]; Papaverine chlorohydrate; Papaverine monohydrochloride; Papaverinium chloride; Pavabid Hp; Qua bid; EV1; RS 47; TNP00305; Alapav (TN); Albatran (TN); Artegodan (TN); Cardiospan (TN); Cardioverina (TN); Cepaverin (TN); Cerebid (TN); Cerespan (TN); Delapav (TN); Dicertan (TN); Dilaves (TN); Dispamil (TN); Drapavel (TN); Durapav (TN); Dynovas (TN); Forpaven (TN); Houde (TN); Mesotina (TN); Myobid (TN); Opdensit (TN); Optenyl (TN); Pameion (TN); Pamelon (TN); Panergon (TN); Papacon (TN); Papalease (TN); Papanerin-hcl; Papaverine (BAN); Papaversan (TN); Pavabid (TN); Pavacap (TN); Pavacen (TN); Pavadel (TN); Pavadyl (TN); Pavagen (TN); Pavakey (TN); Pavased (TN); Pavatest (TN); Paverina (TN); Paverolan (TN); Paveron (TN); Pavnell (TN); Qua bid (TN); Ro-Papav; Therapav (TN); Vasal (TN); Vaso-Pav; Vasospan (TN); Papanerin-hcl (TN); Papaverin-Hamelin (TN); Papital T.R.; Paptial T.R.; Ro-Papav (TN); S-M-R; Spasmo-Nit (TN); Vaso-Pav (TN); Pap-Kaps-150 (TN); Papital T.R. (TN); Paptial T.R. (TN); Isoquinoline,6,7-dimethoxy-1-veratryl-(8CI); Isoquinoline, 6,7-dimethoxy-1-veratryl-(8Cl); 1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline; 1-(3,4-Dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline; 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline; 1-[(3,4-Dimethoxyphenyl)methyl]6,7-dimethoxyisoquinoline; 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline; 1-{[3,4-bis(methyloxy)phenyl]methyl}-6,7-bis(methyloxy)isoquinoline; 4-[(6,7-Dimethoxyisoquinolyl)methyl]-1,2-dimethoxybenzene; 6,7-Dimethoxy-1-(3,4-dimethoxybenzyl)isoquinoline; 6,7-Dimethoxy-1-veratrylisoquinoline
Drug Type
Small molecular drug
Indication Spasm [ICD9: 728.85; ICD10:R25.2] Approved [550750]
Therapeutic Class
Vasodilator Agents
Structure
Download
2D MOL

3D MOL

Formula
C20H21NO4
Canonical SMILES
COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
InChI
1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3
InChIKey
XQYZDYMELSJDRZ-UHFFFAOYSA-N
CAS Number
CAS 61-25-6
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
A03AD01; G04BE02
SuperDrug CAS ID
cas=000058742
Target and Pathway
Target(s) CGMP-specific 3',5'-cyclic phosphodiesterase Target Info Inhibitor [535712]
KEGG Pathway Purine metabolism
cGMP-PKG signaling pathway
NetPath Pathway TGF_beta_Receptor Signaling Pathway
Reactome cGMP effects
References
Ref 550750Drug information of Papaverine, 2008. eduDrugs.
Ref 535712Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J Androl. 2003 Mar;5(1):15-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.